Nicoletta Loggia
Förmögenhet: 22 352 $ per 2026-09-30
Förmögenhet: 22 352 $ per 2026-09-30
Nicoletta Loggia is currently an Independent Director at Candel Therapeutics, Inc. since 2023 and Chief Technical Officer at Orchard Therapeutics Plc since 2021.
Formerly, Dr. Loggia was Head of Cell & Gene Therapies at Novartis AG from 2015 to 2021.
Education includes graduate and doctorate degrees from the University of Pavia.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-09-30 | 2 141 ( 0 % ) | 22 352 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| ORCHARD THERAPEUTICS PLC | Teknisk/Vetenskaplig/F&U Direktör | 2021-09-09 |
| CANDEL THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2023-06-07 |
| Företag | Position | Slut |
|---|---|---|
| NOVARTIS AG | Företagsledare/Principal | 2021-08-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Pavia
University of Pavia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Orchard Therapeutics Plc
Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån